Product Information
NICOTINE 4 MG LOZENGE is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.3360 per EA under NDC 45802087305. Its NADAC has been published 637 times since Jun 11, 2014.
FDA first approved this application on Jan 31, 2006.
Strength
4 mg/1
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802087305
Classification
Generic
Dosage Form
LOZENGE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
NICOTINEApproval Type
Generic (ANDA)
FDA Application
ANDA077007FDA Approved
1/31/2006
On Market Since
3/31/2014
Pharmacological Classes
Price Statistics
The NADAC for NICOTINE 4 MG LOZENGE has been published 637 times since Jun 11, 2014, and over the history we have for it it has declined 6.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3360 per EA |
|---|---|
| All-time high | $0.4244 (Oct 11, 2017) |
| All-time low | $0.3069 (Apr 17, 2024) |
| 52-week high | $0.3399 |
| 52-week low | $0.3269 |
| Median price | $0.3544 |
| Average price | $0.3543 |
| Largest weekly change | +17.9% (Sep 20, 2017) |
| Weeks tracked | 637 |
| Tracking since | Jun 11, 2014 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NICOTINE 4 MG LOZENGE?
The current National Average Drug Acquisition Cost (NADAC) for NICOTINE 4 MG LOZENGE, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.3360 per EA (NDC 45802087305), effective Aug 19, 2026.
How has the price of NICOTINE 4 MG LOZENGE changed over time?
Over the history we have for it, the NADAC for NICOTINE 4 MG LOZENGE has declined 6.7%. It has been tracked across 637 weekly CMS publications since Jun 11, 2014.
What are the highest and lowest recorded NADAC prices for NICOTINE 4 MG LOZENGE?
Since Jun 11, 2014, the NADAC for NICOTINE 4 MG LOZENGE has ranged from a low of $0.3069 (Apr 17, 2024) to a high of $0.4244 (Oct 11, 2017), with a median of $0.3544 per EA.
Are there cheaper alternatives to NICOTINE 4 MG LOZENGE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as NICOTINE 4 MG LOZENGE in a comparable dosage form, but none are currently priced below it.
Who manufactures NICOTINE 4 MG LOZENGE?
NICOTINE 4 MG LOZENGE (NDC 45802087305) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.